Antitrust enforcers get more firepower to take on pay-for-delay deals

Antitrust enforcers will have another weapon in their arsenal when going after drugmakers for anticompetitive practices because of a measure signed by President Donald Trump earlier this month....

Already a subscriber? Click here to view full article